Pubmed    Pubmed Central
uBio Home | uBioRSS

WebSearchLiteratureMolecularImages

 uBio  Web Results 71 - 80 of about 706

Scientific:
   Anethum graveolens (Krop) 

Synonyms:
   Anethum graveolens (dill) 
   Lomatium graveolens graveolens (king desertparsley) 
   Peucedanum graveolens 

Broader Terms:
   Anethum (dill) 
   Apiales 
   Peucedanum 

More Specific:
   Peucedanum graveolens alpinum 
 
 
Latest Articles on Krop from uBioRSS
Diversity of flora used for the cure of equine diseases in selected peri-ur... - Journal of Ethnobiology and Ethnomedicine
Development and validation of a real-time PCR method for the simultaneous d... - ScienceDirect Search: species


Anethum graveolens
USDA-NRCS PLANTS Database

External Resources:



71.  Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer.LinkIT
Tanioka M, Fan C, Parker JS, Hoadley KA, Hu Z, Li Y, Hyslop TM, Pitcher BN, Soloway MG, Spears PA, Henry LN, Tolaney S, Dang CT, Krop IE, Harris LN, Berry DA, Mardis ER, Winer EP, Hudis CA, Carey LA, Perou CM
Clinical cancer research : an official journal of the American Association for Cancer Research, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

72.  Efficacy of essential oils combination on performance, ileal bacterial counts, intestinal histology and immunocompetence of laying hens fed alternative lipid sources.LinkIT
Mousavi A, Mahdavi AH, Riasi A, Soltani-Ghombavani M
Journal of animal physiology and animal nutrition, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

73.  Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline Update.LinkIT
Ramakrishna N, Temin S, Chandarlapaty S, Crews JR, Davidson NE, Esteva FJ, Giordano SH, Kirshner JJ, Krop IE, Levinson J, Modi S, Patt DA, Perlmutter J, Winer EP, Lin NU
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

74.  Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline Update.LinkIT
Giordano SH, Temin S, Chandarlapaty S, Crews JR, Esteva FJ, Kirshner JJ, Krop IE, Levinson J, Lin NU, Modi S, Patt DA, Perlmutter J, Ramakrishna N, Winer EP, Davidson NE
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

75.  A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".LinkIT
Strauss WE, Franklin Adkinson N, Macdougall IC, Auerbach M, Kaper RF, Chertow GM, Krop JS
American journal of hematology, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

76.  Stability of individual LPS-induced ex vivo cytokine release in a whole blood assay over a five-year interval.LinkIT
Spierenburg EAJ, Portengen L, Smit LAM, Krop EJM, Hylkema MN, Rijkers GT, Heederik D, Wouters IM
Journal of immunological methods, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

77.  Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced ERBB2/HER2-Positive Metastatic Breast Cancer: A Phase 1b Clinical Trial.LinkIT
Borges VF, Ferrario C, Aucoin N, Falkson C, Khan Q, Krop I, Welch S, Conlin A, Chaves J, Bedard PL, Chamberlain M, Gray T, Vo A, Hamilton E
JAMA oncology, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

78.  Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer.LinkIT
Kuang Y, Siddiqui B, Hu J, Pun M, Cornwell M, Buchwalter G, Hughes ME, Wagle N, Kirschmeier P, Jänne PA, Paweletz CP, Lin NU, Krop IE, Barry WT, Winer EP, Brown M, Jeselsohn R
NPJ breast cancer, 2018
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0

79.  4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)?. 1634-1657 S0923-7534(19)34113-4 10.1093/annonc/mdy192 Cardoso F F European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt. Senkus E E European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. Costa A A European School of Oncology, Milan, Italy. Papadopoulos E E Europa Donna Cyprus, Nicosia, Cyprus. Aapro M M Oncology Department, Clinique de Genolier, Genolier, Switzerland. André F F Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Harbeck N N Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany. Aguilar Lopez B B Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico. Barrios C H CH Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil. Bergh J J Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden. Biganzoli L L European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy. Boers-Doets C B CB CB Boers Organization, Wormer, The Netherlands. Cardoso M J MJ Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal. Carey L A LA Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA. Cortés J J Department of Oncology, Vall d' Hebron University, Barcelona, Spain. Curigliano G G Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy. Diéras V V Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France. El Saghir N S NS Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. Eniu A A Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania. Fallowfield L L SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK. Francis P A PA Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. Gelmon K K Medical Oncology Department, BC Cancer Agency, Vancouver, Canada. Johnston S R D SRD Department of Medicine, The Royal Marsden, Sutton, UK. Kaufman B B Department of Oncology, Sheba Medical Center, Ramat Gan, Israel. Koppikar S S Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India. Krop I E IE Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA. Mayer M M Advanced BC.org, New York, USA. Nakigudde G G Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda. Offersen B V BV European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. Ohno S S Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan. Pagani O O Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland. Paluch-Shimon S S Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel. Penault-Llorca F F Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France. Prat A A IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain. Rugo H S HS Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. Sledge G W GW Oncology Division, Stanford University Medical Center, Stanford, USA. Spence D D Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia. Thomssen C C Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany. Vorobiof D A DA Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa. Xu B B Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China. Norton L L Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York. Winer E P EP Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA. eng P30 CA016086 CA NCI NIH HHS United States Journal Article Practice Guideline England Ann Oncol 9007735 0923-7534 0 Biomarkers, Tumor IM Biomarkers, Tumor genetics metabolism Biopsy, Large-Core Needle Breast diagnostic imaging pathology surgery Breast Neoplasms diagnosis pathology therapy Chemoradiotherapy, Adjuvant methods standards Clinical Trials as Topic Consensus Development Conferences as Topic Europe Evidence-Based Medicine methods standards Female Humans Integrative Medicine methods standards Mastectomy methods standards Medical Oncology methods standards Neoadjuvant Therapy methods standards Neoplasm Staging Societies, Medical standards Treatment Outcome 2018 7 23 6 0 2019 12 24 6 0 2018 7 23 6 0 ppublish 30032243 S0923-7534(19)34113-4 10.1093/annonc/mdy192 30000937 NBK501877 National Library of Medicine (US) Bethesda (MD) Drugs and Lactation Database (LactMed) 2006 2006 Internet DillLinkIT
Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, Harbeck N, Aguilar Lopez B, Barrios CH, Bergh J, Biganzoli L, Boers-Doets CB, Cardoso MJ, Carey LA, Cortés J, Curigliano G, Diéras V, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Gelmon K, Johnston SRD, Kaufman B, Koppikar S, Krop IE, Mayer M, Nakigudde G, Offersen BV, Ohno S, Pagani O, Paluch-Shimon S, Penault-Llorca F, Prat A, Rugo HS, Sledge GW, Spence D, Thomssen C, Vorobiof DA, Xu B, Norton L, Winer EP
Annals of oncology : official journal of the European Society for Medical Oncology, 2018 08 01 Annals of oncology : official journal of the European Society for Medical Oncology Ann. Oncol. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)?. 1634-1657 S0923-7534(19)34113-4 10.1093/annonc/mdy192 Cardoso F F European School of Oncology (ESO), European Society for Medical Oncology (ESMO) and Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal. Electronic address: fatimacardoso@fundacaochampalimaud.pt. Senkus E E European Society for Medical Oncology (ESMO) and Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. Costa A A European School of Oncology, Milan, Italy. Papadopoulos E E Europa Donna Cyprus, Nicosia, Cyprus. Aapro M M Oncology Department, Clinique de Genolier, Genolier, Switzerland. André F F Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France. Harbeck N N Breast Centre, Department of Obstetrics and Gynaecology, University of Munich (LMU), Munich, Germany. Aguilar Lopez B B Direction Office, ULACCAM (Union Latinoamericana Contra el Cáncer de la Mujer), Mexico DF, Mexico. Barrios C H CH Department of Oncology, PURCS School of Medicine, Porto Alegre, Brazil. Bergh J J Department of Oncology-Pathology, Karolinska Institute & University Hospital, Stockholm, Sweden. Biganzoli L L European Society of Breast Cancer Specialists (EUSOMA) and Department of Medical Oncology, Nuovo Ospedale di Prato - Istituto Toscano Tumori, Prato, Italy. Boers-Doets C B CB CB Boers Organization, Wormer, The Netherlands. Cardoso M J MJ Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation and Nova Medical School, Lisbon, Portugal. Carey L A LA Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, USA. Cortés J J Department of Oncology, Vall d' Hebron University, Barcelona, Spain. Curigliano G G Division of Early Drug Development, Department of Oncology and Hemato-Oncology, European Institute of Oncology, University of Milano, Milano, Italy. Diéras V V Gynaecology and Breast Department, Centre Eugène Marquis, Rennes, France. El Saghir N S NS Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. Eniu A A Breast Cancer Department, Cancer Institute Ion Chiricuta, Cluj-Napoca, Romania. Fallowfield L L SHORE-C, Brighton & Sussex Medical School, University of Sussex, Brighton, UK. Francis P A PA Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. Gelmon K K Medical Oncology Department, BC Cancer Agency, Vancouver, Canada. Johnston S R D SRD Department of Medicine, The Royal Marsden, Sutton, UK. Kaufman B B Department of Oncology, Sheba Medical Center, Ramat Gan, Israel. Koppikar S S Department of Medical Oncology, Bombay Hospital Institute of Medical Sciences, Mumbai, India. Krop I E IE Breast Oncology Center Dana-Farber Cancer Institute, Boston, USA. Mayer M M Advanced BC.org, New York, USA. Nakigudde G G Advocacy Department, UWOCASO (Uganda Women's Cancer Support Organization), Kampala, Uganda. Offersen B V BV European Society of Radiation Oncology (ESTRO) and Department of Experimental Clinical Oncology & Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. Ohno S S Cancer Institute Hospital, Breast Oncology Centre, Tokyo, Japan. Pagani O O Institute of Oncology of Southern Switzerland, Geneva University Hospitals, Swiss Group for Clinical Cancer Research (SAKK), International Breast Cancer Study Group (IBCSG), Bellinzona, Switzerland. Paluch-Shimon S S Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, Israel. Penault-Llorca F F Department of Pathology, Centre Jean Perrin, Clermont-Ferrand Cedex, France. Prat A A IDIBAPS (Institut d'Investigacions Biomèdiques August Pi iSunyer), Hospital Clínic of Barcelona, Translational Genomics and Targeted Therapeutics in Solid Tumor, Barcelona, Spain. Rugo H S HS Breast Oncology Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. Sledge G W GW Oncology Division, Stanford University Medical Center, Stanford, USA. Spence D D Policy Department, Breast Cancer Network Australia, Camberwell, VIC, Australia. Thomssen C C Department of Gynaecology, Martin Luther University Halle-Wittenburg, Halle, Germany. Vorobiof D A DA Oncology Department, Sandton Oncology Centre, Johannesburg, South Africa. Xu B B Department of Medical Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China. Norton L L Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York. Winer E P EP Dana-Farber Cancer Institute, Susan Smith Center for Women's Cancers, Breast Oncology Center, Boston, USA. eng P30 CA016086 CA NCI NIH HHS United States Journal Article Practice Guideline England Ann Oncol 9007735 0923-7534 0 Biomarkers, Tumor IM Biomarkers, Tumor genetics metabolism Biopsy, Large-Core Needle Breast diagnostic imaging pathology surgery Breast Neoplasms diagnosis pathology therapy Chemoradiotherapy, Adjuvant methods standards Clinical Trials as Topic Consensus Development Conferences as Topic Europe Evidence-Based Medicine methods standards Female Humans Integrative Medicine methods standards Mastectomy methods standards Medical Oncology methods standards Neoadjuvant Therapy methods standards Neoplasm Staging Societies, Medical standards Treatment Outcome 2018 7 23 6 0 2019 12 24 6 0 2018 7 23 6 0 ppublish 30032243 S0923-7534(19)34113-4 10.1093/annonc/mdy192 30000937 NBK501877 National Library of Medicine (US) Bethesda (MD) Drugs and Lactation Database (LactMed) 2006
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=0



«12345678